Drug Target Review – Issue #4 2017
Issue 4 of Drug Target Review looks at artificial intelligence in drug discovery and features In-Depth Focuses on Screening, Hit to Lead and Informatics.
List view / Grid view
Issue 4 of Drug Target Review looks at artificial intelligence in drug discovery and features In-Depth Focuses on Screening, Hit to Lead and Informatics.
Researchers have found that amyloid-? facilitates the interaction between the plaques and abnormal tau.
Blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies...
Scientists have detected abnormal prion protein in the skin of patients that have died from Creutzfeldt-Jakob disease...
Researchers identify the sequence and structural factors that drive Tau interaction with membranes...
Nanomapping technology may transform the way disease-causing genetic mutations are diagnosed and discovered...
Researchers have described a unique model for the biology of Alzheimer's disease which may lead to an entirely novel approach for treating the disease...
Researchers have identified a possible genetic basis for coronary artery disease...
Researchers have compiled an atlas of the heart to identify differences between healthy and diseased cells...
Researchers have identified a new protective function for a brain protein genetically linked to Alzheimer's...
CXCR7 receptor identified as a potential therapeutic target for controlling multiple sclerosis, Parkinson's and AIDS...
Non-invasive diagnostic tool measures circulating microRNAs to predict ovarian cancer with specificity...
Researchers have indicated that high levels of a thyroid hormone FT4, are associated with coronary artery disease...
Researchers offer a promising target for future therapies that could potentially root out well-hidden metastatic cancer lesions...
Researchers have developed a vaccine candidate that spurs animals to produce antibodies against protective sugars of multiple HIV strains...